Rekvina Laboratories Limited (BOM:526075)
India · Delayed Price · Currency is INR 54.90
+1.07 (1.99%)
At close: Sep 7, 2026
Rekvina Laboratories Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Assets
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Equivalents | - | 0.15 | 0.25 | 0.1 | 0.1 | 0 |
Cash & Short-Term Investments | 0.15 | 0.15 | 0.25 | 0.1 | 0.1 | 0 |
Cash Growth | -39.04% | -39.04% | 164.21% | -3.06% | 2563.04% | -82.48% |
Accounts Receivable | - | 5.97 | - | - | - | - |
Receivables | - | 5.97 | - | - | - | - |
Other Current Assets | - | 5.77 | 0.07 | - | - | - |
Total Current Assets | - | 11.89 | 0.33 | 0.1 | 0.1 | 0 |
Property, Plant & Equipment | - | - | - | - | 1.46 | 1.46 |
Long-Term Investments | - | - | - | - | 0.46 | 0.46 |
Total Assets | - | 11.89 | 0.33 | 0.1 | 2.02 | 1.92 |
Liabilities
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Accounts Payable | - | 3.94 | 1.07 | 1.14 | 1.06 | 1.76 |
Accrued Expenses | - | 5.5 | 0.11 | 0.01 | 0.02 | 0.03 |
Short-Term Debt | - | 14.73 | 2.47 | 0.4 | 0.81 | - |
Other Current Liabilities | - | - | - | 0.5 | 0 | - |
Total Current Liabilities | - | 24.17 | 3.65 | 2.05 | 1.89 | 1.78 |
Total Liabilities | - | 24.17 | 3.65 | 2.05 | 1.89 | 1.78 |
Shareholders' Equity
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Common Stock | - | 30.14 | 30.14 | 30.14 | 30.14 | 30.14 |
Retained Earnings | - | -42.42 | -33.46 | -32.09 | -30.01 | -30 |
Shareholders' Equity | -12.28 | -12.28 | -3.32 | -1.95 | 0.13 | 0.14 |
Total Liabilities & Equity | - | 11.89 | 0.33 | 0.1 | 2.02 | 1.92 |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Total Debt | 14.73 | 14.73 | 2.47 | 0.4 | 0.81 | - |
Net Cash (Debt) | -14.57 | -14.57 | -2.22 | -0.3 | -0.72 | 0 |
Net Cash Growth | - | - | - | - | - | -82.48% |
Net Cash Per Share | -2.39 | -2.40 | -0.37 | -0.05 | -0.12 | 0.00 |
Filing Date Shares Outstanding | 6.03 | 6.05 | 6.03 | 6.03 | 6.03 | 6.07 |
Total Common Shares Outstanding | 6.03 | 6.05 | 6.03 | 6.03 | 6.03 | 6.07 |
Working Capital | - | -12.28 | -3.32 | -1.95 | -1.79 | -1.78 |
Book Value Per Share | -2.03 | -2.03 | -0.55 | -0.32 | 0.02 | 0.02 |
Tangible Book Value | -12.28 | -12.28 | -3.32 | -1.95 | 0.13 | 0.14 |
Tangible Book Value Per Share | -2.03 | -2.03 | -0.55 | -0.32 | 0.02 | 0.02 |
Land | - | - | - | - | 0.17 | 0.17 |
Buildings | - | - | - | - | 2.03 | 2.02 |
Machinery | - | - | - | - | 2.9 | 2.9 |